You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on DrugBank.
Identification
NameFormaldehyde
Accession NumberDB03843  (EXPT01444)
Typesmall molecule
Groupsexperimental
Description

A highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution (formalin) is considered a hazardous compound, and its vapor toxic. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717)

Structure
Thumb
Synonyms
SynonymLanguageCode
MethanalNot AvailableNot Available
Methyl aldehydeNot AvailableNot Available
Methylene oxideNot AvailableNot Available
OxomethaneNot AvailableNot Available
OxomethyleneNot AvailableNot Available
OxymethyleneNot AvailableNot Available
ParaformNot AvailableNot Available
ParaformaldehydeNot AvailableNot Available
SaltsNot Available
Brand names
NameCompany
FormalinNot Available
FormolNot Available
Brand mixtures
Brand NameIngredients
Buckleys Formo Cresol LiquidCresol + Formaldehyde
Duoplant Plantar Wart TreatmentFormaldehyde + Lactic Acid + Salicylic Acid
Formo CresolCresol + Formaldehyde
Categories
CAS number50-00-0
WeightAverage: 30.026
Monoisotopic: 30.010564686
Chemical FormulaCH2O
InChI KeyWSFSSNUMVMOOMR-UHFFFAOYSA-N
InChI
InChI=1S/CH2O/c1-2/h1H2
IUPAC Name
formaldehyde
SMILES
C=O
Mass SpecNot Available
Taxonomy
KingdomOrganic Compounds
SuperclassOrganonitrogen Compounds
ClassAmines
SubclassPolyamines
Direct parentPolyamines
Alternative parentsNot Available
SubstituentsNot Available
Classification descriptionThis compound belongs to the polyamines. These are compounds containing more than one amine group.
Pharmacology
IndicationNot Available
PharmacodynamicsNot Available
Mechanism of actionNot Available
AbsorptionNot Available
Volume of distributionNot Available
Protein bindingNot Available
Metabolism
Route of eliminationNot Available
Half lifeNot Available
ClearanceNot Available
ToxicityAcute oral toxicity (LD50): 42 mg/kg [Mouse].
Affected organismsNot Available
PathwaysNot Available
SNP Mediated EffectsNot Available
SNP Mediated Adverse Drug ReactionsNot Available
ADMET
Predicted ADMET features
Property Value Probability
Human Intestinal Absorption + 0.9757
Blood Brain Barrier + 0.982
Caco-2 permeable + 0.7834
P-glycoprotein substrate Non-substrate 0.8663
P-glycoprotein inhibitor I Non-inhibitor 0.9633
P-glycoprotein inhibitor II Non-inhibitor 0.9831
Renal organic cation transporter Non-inhibitor 0.9145
CYP450 2C9 substrate Non-substrate 0.8628
CYP450 2D6 substrate Non-substrate 0.9157
CYP450 3A4 substrate Non-substrate 0.8203
CYP450 1A2 substrate Non-inhibitor 0.8503
CYP450 2C9 substrate Non-inhibitor 0.9662
CYP450 2D6 substrate Non-inhibitor 0.9735
CYP450 2C19 substrate Non-inhibitor 0.9531
CYP450 3A4 substrate Non-inhibitor 0.977
CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9443
Ames test AMES toxic 0.645
Carcinogenicity Carcinogens 0.6567
Biodegradation Ready biodegradable 0.7562
Rat acute toxicity 2.5082 LD50, mol/kg Not applicable
hERG inhibition (predictor I) Weak inhibitor 0.9573
hERG inhibition (predictor II) Non-inhibitor 0.9823
Pharmacoeconomics
ManufacturersNot Available
Packagers
Dosage forms
FormRouteStrength
SolutionTopical
PricesNot Available
PatentsNot Available
Properties
Stategas
Experimental Properties
PropertyValueSource
melting point-92 °CPhysProp
boiling point-19.1 °CPhysProp
water solubility4E+005 mg/L (at 20 °C)PICKRELL,JA ET AL. (1983)
logP0.35HANSCH,C ET AL. (1995)
pKa13.3 (at 25 °C)SERJEANT,EP & DEMPSEY,B (1979)
Predicted Properties
PropertyValueSource
water solubility1.98e+02 g/lALOGPS
logP-0.68ALOGPS
logP-0.47ChemAxon
logS0.82ALOGPS
pKa (strongest basic)-6.5ChemAxon
physiological charge0ChemAxon
hydrogen acceptor count1ChemAxon
hydrogen donor count0ChemAxon
polar surface area17.07ChemAxon
rotatable bond count0ChemAxon
refractivity6.31ChemAxon
polarizability2.58ChemAxon
number of rings0ChemAxon
bioavailability1ChemAxon
rule of fiveYesChemAxon
Ghose filterNoChemAxon
Veber's ruleYesChemAxon
MDDR-like ruleNoChemAxon
Spectra
Spectra2D NMR
References
Synthesis Reference

Walter Hasselman, Jr., “Process for the preparation of phenol-urea-formaldehyde condensation products.” U.S. Patent US4345061, issued August, 1926.

US4345061
General ReferenceNot Available
External Links
ResourceLink
KEGG DrugD00017
KEGG CompoundC00067
PubChem Compound712
PubChem Substance46505094
ChEBI16842
ChEMBL
PharmGKBPA449703
IUPHAR4196
Guide to Pharmacology4196
HETFLH
Drugs.comhttp://www.drugs.com/cdi/formaldehyde-solution.html
WikipediaFormaldehyde
ATC CodesNot Available
AHFS CodesNot Available
PDB Entries
FDA labelNot Available
MSDSshow(82.2 KB)
Interactions
Drug InteractionsNot Available
Food InteractionsNot Available

Targets

1. D-alanyl-D-alanine carboxypeptidase

Kind: protein

Organism: Streptomyces sp. (strain R61)

Pharmacological action: unknown

Components

Name UniProt ID Details
D-alanyl-D-alanine carboxypeptidase P15555 Details

References:

  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. Pubmed
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. Pubmed

Comments
comments powered by Disqus
Drug created on June 13, 2005 07:24 / Updated on September 16, 2013 17:22